Proand anti-inflammatory cytokines in children with various clinical forms of chronic glomerulonephritis

Cover Page

Cite item


Aim. Study of the level of pro- and anti-inflammatory cytokines, their relationship and changes, depending on the activity of various variants of chronic glomerulonephritis in children. Methods. 104 children with nephrotic form of chronic glomerulonephritis (group 1), 9 children with hematuric form (group 2) and 88 children with mixed form (group 3) were examined. The average age of children was 10.63±3.88 years. The remission was observed in 130 (45.1%), exacerbation - in 158 (54.9%) patients. The concentration of proinflammatory (interleukin-1β, -8, tumor necrosis factor α, interferon γ) and anti-inflammatory cytokines (interleukin-10 and -4) was determined in the blood by ELISA. Results. A significant increase in the levels of interleukin-1β and -8, tumor necrosis factor α, interferon γ was revealed. The index of cytokines in nephrotic and mixed variant was 2.6 standard units, in hematuric form - 2.5 standard units. More pronounced imbalance of pro- and anti-inflammatory cytokines was revealed in nephrotic and mixed forms of chronic glomerulonephritis. Regardless of the form, an increase was revealed in the ratio of interleukin-1β/interleukin-4 (p <0.05), tumor necrosis factor α/interleukin-4 and tumor necrosis factor α/interleukin-10 (p <0.01). Conclusion. Children with different clinical variants of chronic glomerulonephritis were found to have imbalance of cytokines with the shift towards predominance of proinflammatory cytokines; the most pronounced differences were observed in the content of interleukin-1β and tumor necrosis factor α; both in exacerbation and remission phases cytokine index is higher than 1 which is indicative of active inflammatory process.

About the authors

R O Beglyarov

Azerbaijan Medical University

Author for correspondence.
Baku, Azerbaijan


  1. Детская нефрология. Руководство для врачей. Под ред. М.С. Игнатовой. Изд. 3-е, перераб. и доп. М.: МИА. 2011; 696 c.
  2. Imig J.D., Ryan M.J. Immune and inflammatory role in renal disease. Compr. Physiol. 2013; 3 (2): 957-976. doi: 10.1002/cphy.c120028.
  3. Жизневская И.И., Хмелевская И.Г., Разинькова Н.С. и др. Иммунные предикторы хронического течения гломерулонефрита у детей. Фундаментал. исслед. 2015; (1-6): 1161-1165.
  4. Kurts Ch., Panzer U., Anders H.-J., Rees A.J. The immune system and kidney disease: basic concepts and clinical implications. Nature Rev. Immunol. 2013; 13: 738-753. doi: 10.1038/nri3523.
  5. Ifuku M., Miyake K., Watanebe M. et al. Various roles of Th cytokine mRNA expression in different forms of glomerulonephritis. Amer. J. Nephrol. 2013; 38 (2): 115-123. doi: 10.1159/000353102.
  6. Suárez-Fueyo A., Bradley S.J., Klatzmann D., Tsokos G.C. T-cells and autoimmune kidney disease. Nature Rev. Nephrol. 2017; 13: 329-343. doi: 10.1038/nrneph.2017.34.
  7. Орадова А.Ш., Устенова Г.О., Стабаева Г.С. Методы исследования цитокинов (обзорная статья). Medicine. 2014; (10): 84-87.
  8. Юдина Т.В., Сааркоппель Л.М., Крючкова Е.Н. и др. Способ диагностики нарушения цитокинового баланса организма человека. Патент на изобретение №2463609. Бюлл. №28 от 10.10.2012.
  9. Карзакова Л.М., Автономова О.И., Степанова И.М. и др. Особенности цитокинового статуса при различных вариантах гломерулонефрита. Клин. лаб. диагностика. 2015; (6): 33-36.
  10. Stangou M., Bantis C., Skoularopoulou M. et al. Th1, Th2 and Treg/T17 cytokines in two types of proliferative glomerulonephritis. Indian J. Nephrol. 2016; 26 (3): 159-166. doi: 10.4103/0971-4065.159303.
  11. Жизневская И.И., Хмелевская И.Г. Особенности цитокинового профиля при гломерулопатиях у детей. Курский науч.-практ. вестн. «Человек и его здоровье». 2013; (1): 62-66.
  12. Zwiech R. Predictive value of conjointly examined IL-1ra, TNF-RI, TNF-RII, and RANTES in patients with primary glomerulonephritis. J. Korean Med Sci. 2013; 28 (2): 261-267. doi: 10.3346/jkms.2013.28.2.261.

© 2017 Beglyarov R.O.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies